1
Dinnessen, Manette A.W., van der Poel, Marjolein W.M., Tonino, Sanne H., Visser, Otto, Blijlevens, Nicole M.A., de Jong, Daphne, Lam, King H., Kersten, Marie José, Lugtenburg, Pieternella J., Dinmohamed, Avinash G.
Veröffentlicht in: Dinnessen , M A W , van der Poel , M W M , Tonino , S H , Visser , O , Blijlevens , N M A , de Jong , D , Lam , K H , Kersten , M J , Lugtenburg , P J & Dinmohamed , A G 2021 , ' Stage-specific trends in primary therapy and survival in follicular lymphoma : a nationwide population-based analysis in the Netherlands, 1989–2016 ' , Leukemia , vol. 35 , no. 6 , pp. 1683-1695 . https://doi.org/10.1038/s41375-020-01048-6;
2021
Veröffentlicht in: Dinnessen , M A W , van der Poel , M W M , Tonino , S H , Visser , O , Blijlevens , N M A , de Jong , D , Lam , K H , Kersten , M J , Lugtenburg , P J & Dinmohamed , A G 2021 , ' Stage-specific trends in primary therapy and survival in follicular lymphoma : a nationwide population-based analysis in the Netherlands, 1989–2016 ' , Leukemia , vol. 35 , no. 6 , pp. 1683-1695 . https://doi.org/10.1038/s41375-020-01048-6;
2021
2
Spanjaart, Anne M., Pennings, Elise R.A., Mutsaers, Pim G.N.J., van Dorp, Suzanne, Jak, Margot, van Doesum, Jaap A., de Boer, Janneke W., Niezink, Anne G.H., Kos, Milan, Vermaat, Joost S.P., Sijs-Szabo, Aniko, van der Poel, Marjolein W.M., Nijhof, Inger S., Kuipers, Maria T., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Serroukh, Yasmina I.M., Minnema, Monique C., van Meerten, Tom, Kersten, Marie José
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023